• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高胰岛素血症促有丝分裂影响的机制。

Mechanism of the mitogenic influence of hyperinsulinemia.

机构信息

Division of Endocrinology, Department of medicine, University of Colorado, Denver, USA.

出版信息

Diabetol Metab Syndr. 2011 Jun 13;3(1):10. doi: 10.1186/1758-5996-3-10.

DOI:10.1186/1758-5996-3-10
PMID:21668983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3125332/
Abstract

Either endogenous or exogenous hyperinsulinemia in the setting of insulin resistance promotes phosphorylation and activation of farnesyltransferase, a ubiquitous enzyme that farnesylates Ras protein. Increased availability of farnesylated Ras at the plasma membrane enhances mitogenic responsiveness of cells to various growth factors, thus contributing to progression of cancer and atherosclerosis. This effect is specific to insulin, but is not related to the type of insulin used. Stimulatory effect of hyperinsulinemia on farnesyltransferase in the presence of insulin resistance represents one potential mechanism responsible for mitogenicity and atherogenicity of insulin.

摘要

无论是内源性还是外源性的胰岛素抵抗导致的高胰岛素血症,都会促进法呢基转移酶的磷酸化和激活,法呢基转移酶是一种普遍存在的酶,可将 Ras 蛋白法尼基化。质膜中法尼基化 Ras 的可用性增加会增强细胞对各种生长因子的有丝分裂反应性,从而促进癌症和动脉粥样硬化的进展。这种作用是胰岛素特有的,与所用胰岛素的类型无关。胰岛素抵抗状态下高胰岛素血症对法尼基转移酶的刺激作用代表了胰岛素促有丝分裂和动脉粥样硬化作用的一个潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e32/3125332/34ee6c4c326f/1758-5996-3-10-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e32/3125332/34ee6c4c326f/1758-5996-3-10-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e32/3125332/34ee6c4c326f/1758-5996-3-10-1.jpg

相似文献

1
Mechanism of the mitogenic influence of hyperinsulinemia.高胰岛素血症促有丝分裂影响的机制。
Diabetol Metab Syndr. 2011 Jun 13;3(1):10. doi: 10.1186/1758-5996-3-10.
2
Mitogenic action of insulin: friend, foe or 'frenemy'?胰岛素的有丝分裂作用:朋友、敌人还是“敌友”?
Diabetologia. 2010 Feb;53(2):229-33. doi: 10.1007/s00125-009-1558-6. Epub 2009 Oct 23.
3
Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues.胎儿高胰岛素血症会增加胎儿组织中p21 Ras的法尼基化。
Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E217-23. doi: 10.1152/ajpendo.2001.281.2.E217.
4
Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects.显性负性法尼基转移酶α亚基抑制胰岛素促有丝分裂作用。
Biochem Biophys Res Commun. 2001 Jul 13;285(2):161-6. doi: 10.1006/bbrc.2001.5142.
5
What does insulin do to Ras?
Cell Signal. 1998 May;10(5):297-301. doi: 10.1016/s0898-6568(97)00132-0.
6
Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase.定义酿酒酵母蛋白质法尼基转移酶的类异戊二烯和CAAX偏好性的氨基酸残基。打造完美的法尼基转移酶。
J Biol Chem. 1998 Apr 17;273(16):9472-9. doi: 10.1074/jbc.273.16.9472.
7
Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.胰岛素对异戊二烯化的影响,作为高胰岛素血症潜在有害影响的一种机制。
Endocrinology. 2000 Apr;141(4):1310-6. doi: 10.1210/endo.141.4.7411.
8
Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells.
Endocrinology. 1998 Oct;139(10):4067-72. doi: 10.1210/endo.139.10.6270.
9
Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.胰岛素对3T3-L1脂肪细胞中法尼基转移酶活性的影响。
J Biol Chem. 1996 Nov 1;271(44):27585-9. doi: 10.1074/jbc.271.44.27585.
10
GTP loading of farnesylated p21Ras by insulin at the plasma membrane.胰岛素在质膜上使法尼基化的p21Ras进行GTP加载。
Biochem Biophys Res Commun. 1997 Oct 9;239(1):42-5. doi: 10.1006/bbrc.1997.7413.

引用本文的文献

1
Integrating the metabolic and molecular circuits in diabetes, obesity and cancer: a comprehensive review.整合糖尿病、肥胖症和癌症中的代谢与分子回路:综述
Discov Oncol. 2024 Dec 18;15(1):779. doi: 10.1007/s12672-024-01662-1.
2
Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R level.多层次蛋白质组学鉴定了胰岛素通过 ERK 通路诱导 EphA2 受体上调,该过程依赖于低 IGF1R 水平。
Sci Rep. 2024 Nov 21;14(1):28856. doi: 10.1038/s41598-024-77817-5.
3
Insulin Resistance, Hyperinsulinemia and Atherosclerosis: Insights into Pathophysiological Aspects and Future Therapeutic Prospects.

本文引用的文献

1
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.甘精胰岛素的使用与短期恶性肿瘤发病风险:一项基于人群的瑞典随访研究。
Diabetologia. 2009 Sep;52(9):1745-54. doi: 10.1007/s00125-009-1444-2. Epub 2009 Jul 9.
2
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.二甲双胍与糖尿病乳腺癌患者对新辅助化疗的病理完全缓解
J Clin Oncol. 2009 Jul 10;27(20):3297-302. doi: 10.1200/JCO.2009.19.6410. Epub 2009 Jun 1.
3
Diet, delusion and diabetes.
胰岛素抵抗、高胰岛素血症与动脉粥样硬化:对病理生理方面及未来治疗前景的见解
Curr Cardiol Rev. 2025;21(1):e1573403X314035. doi: 10.2174/011573403X314035241006185109.
4
Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females.酮症抑制与衰老(KetoSAge)第二部分:抑制酮症对健康女性中与衰老相关的生物标志物、胰岛素抵抗指数(HOMA-IR)、瘦素、骨钙素和胰高血糖素样肽-1的影响。
Biomedicines. 2024 Jul 12;12(7):1553. doi: 10.3390/biomedicines12071553.
5
Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis.血糖特征与韩国患者结直肠癌生存的关系:一项基于孟德尔随机化的分析。
Cancer Med. 2024 Mar;13(5):e7084. doi: 10.1002/cam4.7084.
6
Light and Shadow of Na-Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Points for Improvement Based on Our Clinical Experience.钠-葡萄糖协同转运蛋白2抑制剂治疗糖尿病的利弊:基于临床经验的改进要点
Int J Endocrinol. 2024 Jan 25;2024:3937927. doi: 10.1155/2024/3937927. eCollection 2024.
7
Bio-Hacking Better Health-Leveraging Metabolic Biochemistry to Maximise Healthspan.生物黑客助力健康——利用代谢生物化学最大化健康寿命。
Antioxidants (Basel). 2023 Sep 11;12(9):1749. doi: 10.3390/antiox12091749.
8
Pancreatic Cancer and the Obesity Epidemic: A Narrative Review.胰腺癌与肥胖流行:一篇综述
Cureus. 2022 Jul 8;14(7):e26654. doi: 10.7759/cureus.26654. eCollection 2022 Jul.
9
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.二甲双胍可拮抗胰岛素对原发性乳腺癌细胞的刺激作用。
J Transl Med. 2022 Jun 7;20(1):263. doi: 10.1186/s12967-022-03463-y.
10
Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis.胰岛素治疗对心力衰竭合并糖尿病患者结局的影响:系统评价和荟萃分析。
Diab Vasc Dis Res. 2022 May-Jun;19(3):14791641221093175. doi: 10.1177/14791641221093175.
饮食、错觉与糖尿病。
Diabetologia. 2009 Jan;52(1):1-7. doi: 10.1007/s00125-008-1203-9.
4
Effects of chronic hyperinsulinemia in insulin-resistant patients.慢性高胰岛素血症对胰岛素抵抗患者的影响。
Curr Diab Rep. 2008 Jun;8(3):233-8. doi: 10.1007/s11892-008-0040-z.
5
Increased farnesylation of p21-Ras and neonatal macrosomia in women with gestational diabetes.妊娠期糖尿病女性中p21-Ras法尼基化增加与新生儿巨大儿
J Pediatr. 2006 Dec;149(6):871-3. doi: 10.1016/j.jpeds.2006.08.071.
6
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.使用磺脲类药物或胰岛素的2型糖尿病患者癌症相关死亡率增加。
Diabetes Care. 2006 Feb;29(2):254-8. doi: 10.2337/diacare.29.02.06.dc05-1558.
7
Molecular mechanisms of insulin resistance that impact cardiovascular biology.影响心血管生物学的胰岛素抵抗分子机制。
Diabetes. 2004 Nov;53(11):2735-40. doi: 10.2337/diabetes.53.11.2735.
8
Enhanced insulin signaling via Shc in human breast cancer.通过Shc增强人乳腺癌中的胰岛素信号传导。
Metabolism. 2003 Dec;52(12):1606-11. doi: 10.1016/s0026-0495(03)00311-1.
9
Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells.
J Biol Chem. 2002 Jan 18;277(3):1794-9. doi: 10.1074/jbc.M103728200. Epub 2001 Nov 13.
10
Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues.胎儿高胰岛素血症会增加胎儿组织中p21 Ras的法尼基化。
Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E217-23. doi: 10.1152/ajpendo.2001.281.2.E217.